Improving Emergency Department Testing for Deep Vein Thrombosis

Status Recruiting

Clinical Trial Summary

This observational study will use a new way to test for deep vein thrombosis (DVT) of the leg. A DVT is a blood clot in the leg and is a medical problem that can cause swelling, pain, and redness. If the blood clot is not treated, it can cause more serious, long-term effects, and occasionally lead to death. The main questions the study aims to answer are: 1. How safe is our new blood clot testing method? 2. How efficient is our new blood clot testing method? The study will be run in the emergency department and urgent care centre in Kingston, Ontario. Patients who are tested for a DVT in the leg can be included in the study. Researchers follow the patient through chart review to make sure the new system is safe and efficient.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06195787
Study type	Observational
Source	Queen's University
Contact	Natasha Clayton
Phone	4165663590
Email	nc96@queensu.ca
Status	Recruiting
Phase
Start date	January 1, 2024
Completion date	December 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02523937` - Evaluation of Soluble Fibrin in Thrombosis Exclusion
Terminated	`NCT03805672` - Below Knee DVT Study	Phase 4
Completed	`NCT00986154` - Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).	Phase 3
Completed	`NCT02205294` - Osteopathic Treatment and Deep Vein Thrombosis (DVT)	N/A
Completed	`NCT02798471` - Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)	Phase 3
Completed	`NCT02210819` - Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Completed	`NCT01630148` - Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries	N/A
Completed	`NCT02073682` - Cancer Venous Thromboembolism (VTE)	Phase 3
Recruiting	`NCT02342444` - Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)	Phase 4
Completed	`NCT02744092` - Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer	N/A
Recruiting	`NCT02156401` - VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE